133 related articles for article (PubMed ID: 32485087)
1. Hyperforin induces apoptosis through extrinsic/intrinsic pathways and inhibits EGFR/ERK/NF-κB-mediated anti-apoptotic potential in glioblastoma.
Hsu FT; Chen WT; Wu CT; Chung JG
Environ Toxicol; 2020 Oct; 35(10):1058-1069. PubMed ID: 32485087
[TBL] [Abstract][Full Text] [Related]
2. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
[TBL] [Abstract][Full Text] [Related]
3. Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells.
Chiang IT; Chen WT; Tseng CW; Chen YC; Kuo YC; Chen BJ; Weng MC; Lin HJ; Wang WS
Anticancer Res; 2017 Jan; 37(1):161-167. PubMed ID: 28011486
[TBL] [Abstract][Full Text] [Related]
4. Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-ĸB-modulated Survival and Invasion Potential in Bladder Cancer.
Liu YC; Lin KH; Hsieh JH; Chung JG; Tan ZL; Hsu FT; Chiang CH
In Vivo; 2019; 33(6):1865-1877. PubMed ID: 31662514
[TBL] [Abstract][Full Text] [Related]
5. Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.
Chen WT; Chen YK; Lin SS; Hsu FT
Anticancer Res; 2018 Apr; 38(4):2161-2167. PubMed ID: 29599335
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
[TBL] [Abstract][Full Text] [Related]
7. St. John's wort extract and hyperforin inhibit multiple phosphorylation steps of cytokine signaling and prevent inflammatory and apoptotic gene induction in pancreatic β cells.
Novelli M; Menegazzi M; Beffy P; Porozov S; Gregorelli A; Giacopelli D; De Tata V; Masiello P
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):92-104. PubMed ID: 27780755
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into the antileukemic activity of hyperforin.
Billard C; Merhi F; Bauvois B
Curr Cancer Drug Targets; 2013 Jan; 13(1):1-10. PubMed ID: 22924417
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.
Jakobs D; Hage-Hülsmann A; Prenner L; Kolb C; Weiser D; Häberlein H
J Pharm Pharmacol; 2013 Jun; 65(6):907-15. PubMed ID: 23647684
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-κB signalling participate in anti-glioblastoma of imipramine.
Hsu FT; Chiang IT; Wang WS
J Cell Mol Med; 2020 Apr; 24(7):3982-4000. PubMed ID: 32149465
[TBL] [Abstract][Full Text] [Related]
11. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
[TBL] [Abstract][Full Text] [Related]
12. Hyperforin: more than an antidepressant bioactive compound?
Medina MA; Martínez-Poveda B; Amores-Sánchez MI; Quesada AR
Life Sci; 2006 Jun; 79(2):105-11. PubMed ID: 16438991
[TBL] [Abstract][Full Text] [Related]
13. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
Bouron A; Lorrain E
Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
[TBL] [Abstract][Full Text] [Related]
14. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
[TBL] [Abstract][Full Text] [Related]
15. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
Martínez-Poveda B; Quesada AR; Medina MA
Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212
[TBL] [Abstract][Full Text] [Related]
16. Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.
Kraus B; Wolff H; Elstner EF; Heilmann J
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):541-53. PubMed ID: 20369228
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
[TBL] [Abstract][Full Text] [Related]
18. Persistence of STAT-1 inhibition and induction of cytokine resistance in pancreatic β cells treated with St John's wort and its component hyperforin.
Novelli M; Beffy P; Gregorelli A; Porozov S; Mascia F; Vantaggiato C; Masiello P; Menegazzi M
J Pharm Pharmacol; 2019 Jan; 71(1):93-103. PubMed ID: 28990659
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.
Schempp CM; Kirkin V; Simon-Haarhaus B; Kersten A; Kiss J; Termeer CC; Gilb B; Kaufmann T; Borner C; Sleeman JP; Simon JC
Oncogene; 2002 Feb; 21(8):1242-50. PubMed ID: 11850844
[TBL] [Abstract][Full Text] [Related]
20. Reduction of high-affinity beta2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy.
Prenner L; Sieben A; Zeller K; Weiser D; Häberlein H
Biochemistry; 2007 May; 46(17):5106-13. PubMed ID: 17417877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
